Stem Cell Transplantation

Feb 29, 2020
The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis
Light-chain (AL) amyloidosis is a systemic syndrome characterized by progressive organ dysfunction leading to organ failure and death. The heart is the most…
Read more
Jan 27, 2020
Efficacy of Chemotherapies and Stem Cell Transplantation for Systemic AL Amyloidosis: A Network Meta-Analysis
Background/Aims: The present Bayesian network meta-analysis (NMA) was to compare the efficacy of different chemotherapies and autologous stem cell transplantation (…
Read more
Dec 13, 2018
Complete Remission of Both Immunoglobulin Light Chain Amyloidosis and Psoriasis After Autologous Hematopoietic Stem Cell Transplantation
Rationale: Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the deposition of abnormal amyloid protein produced by a pathological plasma…
Read more
Dec 25, 2016
New and Developing Therapies for AL Amyloidosis
Systemic light-chain (AL) amyloidosis is an infiltrative disorder associated with an underlying plasma cells dyscrasia, in which monoclonal immunoglobulin light…
Read more
surbhi-sidana
Surbhi Sidana, MD
Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…
Read more
surbhi-sidana
Surbhi Sidana, MD
Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…
Read more
Subscribe to